Oculgen enrolls first US patient in global phase 2/3 wet AMD trial – Eyes On Eyecare

Oculgen enrolls first US patient in global phase 2/3 wet AMD trial  Eyes On Eyecare

RCM Expert
1–2 minutes

Oculgen enrolls first US patient in global phase 2/3 wet AMD trial  Eyes On Eyecare

Leave a Reply

Trending

Discover more from Ophthalmology News USA

Subscribe now to keep reading and get access to the full archive.

Continue reading